Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE) † † 2011 ASCO Annual meeting: Poster Session; 2012 ASCO Annual meeting: Poster Session; 2013 ASCO Annual meeting: Poster Session; 2014 ASCO Annual meeting: Abstract; ESMO 2012 Congress Vienna: Oral presentation; European Cancer Congress 2013: Poster Session; Sociedad Española de Oncología Médica (SEOM) 2013: Oral presentation.
Titel:
Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE) † † 2011 ASCO Annual meeting: Poster Session; 2012 ASCO Annual meeting: Poster Session; 2013 ASCO Annual meeting: Poster Session; 2014 ASCO Annual meeting: Abstract; ESMO 2012 Congress Vienna: Oral presentation; European Cancer Congress 2013: Poster Session; Sociedad Española de Oncología Médica (SEOM) 2013: Oral presentation.
Auteur:
Grande, E. Capdevila, J. Castellano, D. Teulé, A. Durán, I. Fuster, J. Sevilla, I. Escudero, P. Sastre, J. García-Donas, J. Casanovas, O. Earl, J. Ortega, L. Apellaniz-Ruiz, M. Rodriguez-Antona, C. Alonso-Gordoa, T. Díez, J.J. Carrato, A. García-Carbonero, R.